INTRODUCTION
During metazoan development, the growth of different tissues must be strictly coordinated. One way in which this is achieved is by the use of systemically acting growth hormones. Since growth is dependent upon the availability of nutrients, the production or secretion of growth hormones is often responsive to nutrient status. In the past decade it has become clear that several of the hormones that were initially identified in mammals also regulate growth in distantly related organisms such as Drosophila melanogaster and Caenorhabditis elegans. Studies with these invertebrates are providing new insights into how growth is modulated in response to changing nutrient availability.
Postembryonic development in C. elegans in the presence of abundant nutrients and under other conditions promoting growth involves four larval stages (L1-L4) and an adult stage. Reduction in nutrient availability can have one of several effects, depending upon the stage at which nutrients become limiting. When eggs hatch in the absence of food, the L1 larvae that emerge arrest growth reversibly. They resume normal growth when food is provided (Johnson et al., 1984) . If late L1 or early L2 larvae are deprived of food, a decision is made not to progress through the normal (reproductive) life cycle via the L3 stage, but rather to enter an alternative developmental state, termed dauer, that is adapted for survival under harsh conditions (Albert et al., 1981; Cassada and Russell, 1975; Li et al., 2003) . When L4 worms are deprived of food, cell growth is much reduced and the adult worms they give rise to are much smaller in size.
Normal reproductive growth is promoted by four pairs of sensory neurons, ASI, ADF, ASG, and ASJ (Bargmann and Horvitz, 1991) . In the presence of abundant food, and under other conditions conducive to normal growth, ASI promotes reproductive (nondauer) growth by secreting DAF-28, an insulin-like protein, and DAF-7, a TGFb pathway ligand. When food becomes scarce, however, production of DAF-28 and DAF-7 is reduced. DAF-28 acts through a conserved signaling pathway involving the insulin/IGF1 receptor homolog, DAF-2 (Li et al., 2003) . DAF-28 is also expressed in the posterior intestine (Li et al., 2003) , suggesting that its levels could be regulated in response to altered metabolism in this tissue. DAF-28 appears to be regulated at the level of both transcription and secretion (Ailion et al., 1999; Li et al., 2003) . However, how nutrient levels are able to affect the production or secretion of DAF-28 and other insulinlike proteins is incompletely understood.
Several observations suggest that insulin/IGF1 signaling (IIS) is also involved in regulating L1 arrest. First, a strong allele of daf-2, e979, causes arrest at the L1 stage (Gems et al., 1998) . Second, overexpression of an inhibitory insulin-like protein, INS-1, in the background of a mutation that reduces daf-2 activity causes L1 arrest (Pierce et al., 2001 ). Third, starved L1 larvae with constitutively active IIS fail to arrest properly (Baugh and Sternberg, 2006; Fukuyama et al., 2006) .
The human gene ASNA1 encodes an ATPase expressed in several tissues of neuroendocrine origin and especially in the pancreatic islets of Langerhans (KurdiHaidar et al., 1996 (KurdiHaidar et al., , 1998 . ASNA1 is exceptionally well conserved during evolution: homologs are present in all eukaryotes as well as some prokaryotes (Rosen, 1999) . All homologs have a completely conserved DTAPTGHT motif, and a predicted ATP binding site, GKGGVGKT, in the Walker A motif. The yeast homolog, Arr4p/Get3p, has been implicated in vesicle transport (Schuldiner et al., 2005) . Deletion of Arr4p or of the protein with which it forms a tight complex, Get1p, causes defects in secretion. The localization of the complex changes in response to nutrient levels: in rich media the complex is present on the ER, but when cells are moved to minimal media, the complex moves to the Golgi (Schuldiner et al., 2005) as well as other vesicular organelles. ASNA1 is essential for mouse development, but its function in metazoans is not known (Mukhopadhyay et al., 2006) . A C. elegans homolog, ASNA-1 (ZK637.5) is predicted to be a 342 amino acid protein with 54% amino acid sequence identity to human ASNA1 (Koonin, 1993) .
Here we report that C. elegans worms lacking asna-1 activity arrest growth at the L1 stage with reduced IIS. asna-1::gfp reporters are expressed in some amphid neurons and in the intestine: cells that also express insulin-like proteins including DAF-28. Increasing asna-1 levels has the same effect on exit from dauer as that caused by increasing the levels of daf-28. Worms with reduced asna-1 activity have less secreted DAF-28. asna-1 function has been conserved in evolution: we show that human ASNA1 is expressed at high levels in pancreatic b cells and that it can rescue the C. elegans asna-1 mutant phenotype. Consistent with the worm results, reducing or increasing ASNA1 function in mouse insulinoma cells causes a reduction or increase in insulin secretion, respectively.
RESULTS
Removal of asna-1 Activity Causes a Reversible Growth Arrest at the L1 Stage Injection of asna-1 dsRNA into C. elegans caused the F1 progeny to arrest at the L1 stage even in the presence of abundant food ( Figures 1B and 1C) . The arrested animals were healthy and moved normally. Two observations suggested that the arrest was reversible and not caused by abnormalities in pattern formation. First, in asna-1(RNAi) animals left for more than 1 week, the effect of the dsRNA wore off and the larvae resumed growth to give rise to apparently normal fertile adults. Second, when ASNA1 activity was provided from a transgene containing a human ASNA1 cDNA under control of a heat shock promoter, the L1 arrested larvae resumed growth following heat shock ( Figure 1C) . Inspection of the arrested L1 larvae under high magnification revealed that most had arrested approximately midway through the L1 stage, similar to daf-2(e979) animals. In most animals, the P cells had migrated from their ventro-lateral positions into the ventral cord. The progenitors of the somatic gonad, Z1 and Z4, had undergone either one or two rounds of division. The arrested worms showed no apparent developmental defects in the nervous system, musculature, gonad, intestine, or hypodermis.
Since RNAi sometimes does not cause complete loss of gene activity, we isolated worms harboring a germline deletion mutation in the gene sv42 (Figure 2 ). The sv42 mutation deletes a 1053 bp region spanning the last exon of the upstream gene ZK637.4, the entire asna-1 promoter, and 502 bp of the coding region. A second mutation, ok938, obtained from the C. elegans gene knockout consortium, deletes 1125 bp and terminates 7 bp beyond the stop codon ( Figure 2 ). No ASNA-1 protein was detected in worms homozygous for either sv42 or ok938 (Figure 2 ), suggesting that these alleles strongly reduce or eliminate gene activity.
The asna-1(sv42) phenotype appears to be caused by the deletion of asna-1 rather than that of ZK637.4. First, the phenotype of asna-1(sv42) is indistinguishable from that caused by asna-1(ok938); second, RNAi against ZK637.4 did not give any obvious mutant phenotype; third, the phenotypes caused by either sv42 or ok938 were rescued by a transgene containing just the asna-1 gene ( Figure 1B) . Homozygous sv42 or ok938 animals segregating from heterozygous mothers all grew up to be scrawny, sterile adults that were thinner than their wild-type siblings (n > 1000) ( Figure 1B ). The homozygous mutants were noticeably smaller from the L2 stage onward, but became adults at the same time as their wildtype siblings. The ability of the mutants to evade arrest at the L1 stage is the result of maternal rescue. asna-1 animals depleted of both maternal and zygotic activity (m-z-) by asna-1 RNAi of mutant heterozygotes invariably arrested as L1 larvae that failed to resume growth even when left for longer periods of time (>1 week, n = 359). Maternally rescued asna-1 worms did not show defects in pattern formation and appeared to contain the wild-type number of somatic cells. Vulval development, for example, was normal.
L1 larvae that are unable to feed because of defects in the feeding organ, called the pharynx, fail to initiate growth in the presence of food (Avery, 1993;  Figure 3 and data not shown). Several observations, however, indicate that this is not the cause of the arrest of asna-1(m-z-) larvae. Pharyngeal pumping was normal (see Figure S1 in the Supplemental Data), arrested animals had bacteria in their intestines, and they were able to ingest fluorescent 0.2 mm diameter beads at a normal rate ( Figure S1 ). The arrest is also not caused by an inability to take up nutrients into the intestine by endocytosis. The endocytosis marker FM4-64 was taken up into the intestine even in L1 arrested asna-1 mutants ( Figure S1 ). L1 arrested worms fed bacteria expressing unc-22 dsRNA showed the twitching phenotype that indicates that intestinal cells could take up and secrete dsRNA. asna-1::gfp Reporters Are Expressed in Cells that Express DAF-28 and Other INS Proteins From computer analysis of the DNA sequence in the region, asna-1 has been predicted to be the fourth gene in an operon together with the genes ZK637.2, ZK637.3, and ZK637.4 (http://ws160.wormbase.org/). We fused gfp to the last codon of asna-1 and generated worms in which expression of the fusion gene was driven by sequences spanning both asna-1 and the genes lying upstream. In worms carrying the transgene, GFP expression was seen in a subset of sensory neurons, in the intestine, and, more weakly, in the hypodermis. The distance between the end of ZK637.4 and the start of asna-1, at 430 bp, is more than four times the usual distance between genes in operons. Therefore, we tested whether the 430 bp fragment alone was sufficient to rescue the asna-1 defects. Indeed, an ASNA-1::GFP fusion protein driven by the 430 bp fragment fully rescued asna-1(sv42) and asna-1(ok938) (Figure 1 ). In worms carrying the transgene, like those harboring the longer construct, GFP expression was seen in a restricted set of sensory neurons, in the intestine, and weakly in the hypodermis (Figure 1 and data not shown). Further analysis of the sensory neuron expression revealed that during the L1 and L2 stages, GFP was invariably expressed in ASI, and often also in ASK. In some animals, expression was also seen in ADL; however, in most animals expression was not seen in all three pairs of neurons simultaneously. These data are consistent with SAGE analysis that also indicates that ASNA-1 is expressed in the gut, in sensory neurons, and in the hypodermis (http://ws160.wormbase.org/). In addition, the SAGE data indicate that besides the neurons we have identified, ASNA-1 may also be expressed in other sensory neurons, including AFD and ASER.
asna-1 Is Required Cell-Nonautonomously for Growth To understand further how asna-1 acts to regulate growth, we tested whether asna-1 was required autonomously or nonautonomously. We tested the ability of asna-1 under the control of tissue-specific promoters to rescue the growth defect. 3/3 transgenes with asna-1::gfp under the control of the osm-6 promoter (P osm-6 ), which is expressed specifically in ciliated sensory neurons (Collet et al., 1998) , and 3/3 transgenes in which asna-1 expression was driven hermaphrodite. svEx412 is a transgene array containing asna-1::gfp under the control of the osm-6 promoter, which is specifically expressed in ciliated sensory neurons. (BF) Wild-type (N2) adult worm harboring the svEx412 array viewed with both Nomarski DIC and fluorescence optics. The ASNA-1::GFP fusion protein is detectable in sensory neuron cell bodies (arrow) and axons (arrowheads), but not in other tissues. (C) Graph showing the proportion of animals arresting at the L1 stage. RNAi for asna-1 was carried out by injecting dsRNA into an adult hermaphrodite. % L1 arrest refers to the proportion of the progeny of the injected animal that were arrested. hs-ASNA1 indicates a transgene array, svEx121, carrying a human ASNA1 cDNA under the control of a C. elegans heat shock-responsive promoter.
by the elt-2 promoter, which is expressed specifically in the intestine (Fukushige et al., 1998) , rescued the asna-1 body size phenotype to the same extent as a transgene containing asna-1 under the control of its own promoter ( Figure 1B ). To complement these experiments with heterologous promoters, we performed genetic mosaic analysis. 6/6 mosaic individuals lacking asna-1 activity in the AB lineage, but being asna-1(+) in the P 1 lineage (from which the intestine is derived) were fully rescued for the growth defect, implying that asna-1 is not required in all cells for growth. 5/5 mosaics that were asna-1(À) in P 1 , but asna-1(+) in AB (from which most sensory neurons are derived), were substantially rescued, although they were not as big as wild-type.
asna-1 Is a Positive Regulator of the Insulin Pathway
The pathway activated by DAF-2 controls entry into dauer by regulating the subcellular localization of the forkhead family transcription factor DAF-16 (Lin et al., 1997; Ogg et al., 1997; Ogg and Ruvkun, 1998; Paradis and Ruvkun, 1998) . In reproductively growing animals, in which IIS is high, DAF-16::GFP is cytoplasmic, whereas in animals with reduced IIS, it is found predominantly in the nucleus (Henderson and Johnson, 2001; Lee et al., 2001; Lin et al., 2001) . In starved L1 larvae, DAF-16::GFP is nuclear (Baugh and Sternberg, 2006) . In 25% (n = 20) of asna-1(sv42) adults, DAF-16::GFP was nuclear (Figure 4 ) (cf. 0% for well-fed asna-1(+) animals, n > 100). Nuclear DAF-16::GFP was also seen in 82% (n = 11) of L1 arrested asna-1(RNAi) animals. Thus, reduced asna-1 activity is associated with translocation of DAF-16::GFP to the nucleus and lowered IIS.
To investigate further the effect of reducing asna-1 activity on IIS, we examined the ability of asna-1 mutations to enhance Daf-c phenotypes caused by mutations affecting entry into dauer. DAF-7 TGFb controls entry into dauer by regulating a signal transduction pathway involving the coreceptors DAF-1 and DAF-4 and the SMAD proteins DAF-14 and DAF-8 (Patterson and Padgett, 2000) . The TGFb and IIS pathways function in parallel to regulate entry into dauer. Mutations in genes in the TGFb and IIS pathways show synergistic effects, such that double mutants in which activity of both pathways is partially reduced enter dauer under conditions in which single mutants progress through the reproductive life cycle (Ogg et al., 1997; Thomas et al., 1993) . Like those of daf-2, asna-1 mutations enhanced the Daf-c phenotype caused by daf-7 at semipermissive temperatures. At 20 C only 2% of daf-7(e1372) single mutant worms entered dauer (n = 230), whereas 100% of daf-7(e1372) asna-1 double mutant worms did so (n = 340). asna-1 mutations (and asna-1 RNAi) also enhanced the Daf-c phenotype caused by a null mutation in unc-31 . unc-31 encodes a homolog of CAPS, a component of dense core vesicles, which mediate the release of insulin from b cells in mammals (Berwin et al., 1998) . unc-31 mutations promote entry into dauer at 27 C (Ailion et al., 1999) . Only 0.2% of unc-31(e928) single mutant worms entered dauer at 25 C (n = 662), whereas 34.2% (n = 105) and 37.5% (n = 122) of asna-1(sv42); unc-31(e928) and asna-1(ok938); unc-31(e928) double mutants, respectively, did so (Figure 4) . Loss of asna-1 activity also enhanced the Daf-c phenotype caused by other mutations, including those in daf-11, daf-14, and daf-8 (see Table S2 in the Supplemental Data). Thus, reduction in asna-1 activity, like reduced IIS, can enhance the Daf-c phenotype caused by mutations that compromise signaling between the amphid neurons and target tissues. Taken together these findings suggest that asna-1 is a positive regulator of IIS.
Overexpression of daf-28 or ins-4 Promotes Exit from Dauer, and Overexpression of asna-1 Mimics Their Effects IIS not only modulates entry into dauer, but is also proposed to play a role in promoting exit from dauer (Tissenbaum et al., 2000) . The muscarinic receptor agonists pilocarpine and arecoline stimulate worms with defective TGFb signaling to exit dauer. It was proposed that these drugs affect dauer exit by stimulating the release of insulin-like proteins that can bypass the requirement for TGFb signaling (Tissenbaum et al., 2000) . Since this phenotype could be used to test the consequences of increased IIS, we examined whether the effects of high gene dosages of daf-28 or ins-4-which can functionally substitute for daf-28 (Li et al., 2003) -could mimic the effects of these drugs on dauer exit. At 25 C, daf-7(e1372), daf-7(m62), daf-1(m40) , and daf-8(e1393) mutants (which all exhibit altered TGFb signaling) or daf-2(e1370) (which exhibit altered IIS signaling) invariably enter dauer and never exit this state (Riddle et al., 1997) . The TGFb pathway mutants that overexpressed daf-28 or ins-4 entered dauer, but exited again soon after, whereas daf-2(e1370) mutants overexpressing ins-4 or daf-28 did not exit dauer (Table 1) . Thus, overexpression of daf-28 or ins-4 can bypass the requirement for the TGFb pathway, but not the insulin pathway, for dauer exit. To examine whether asna-1 could have the same effect, we tested the ability of asna-1 overexpression to promote dauer exit. The transgene arrays svIs54 and svIs56 express elevated levels of a functional ASNA-1::GFP fusion protein (Figure 4 ). Both arrays bypassed the requirement for the TGFb signaling pathway, but not that for insulin signaling (Figure 4 and Table 1). Constitutive asna-1 expression under the control of a sensory neuron-specific promoter from the osm-6 gene also promoted dauer exit (Table 1) . Thus, high asna-1 gene dosage has the same effects on dauer exit as high doses of daf-28 or ins-4. In the background of tm2308, a daf-28 deletion mutation, asna-1 could still bypass the requirement for daf-7; however, it did so less efficiently. daf-7; svIs54 [asna-1(++) ]; daf-28 worms exited dauer only after 5 days. daf-7; svIs54[asna-1(++)] worms did so after 3 days. The results of our mosaic analysis, and the fact that asna-1 driven by the elt-2 intestine-specific promoter rescued the asna-1 growth defect, suggested that one focus for asna-1 is in the intestine. We found that daf-28 could also function in the intestine: the transient dauer defect caused by a dominant daf-28 point mutation, sa191, was partially rescued by wild-type daf-28 driven by the elt-2 promoter (7%, n = 301). Consistent with this result, asna-1 driven by the daf-28 promoter fully rescued the asna-1 growth defect (n R 100). The expression of ASNA-1::GFP was not reduced in daf-2; svIs54 or daf-2; svIs56 dauer larvae (data not shown). Together, these results suggest that ASNA-1 may act by promoting production or release of INS proteins.
ASNA-1 Has ATPase Activity In Vitro that Is Required for Function
In Vivo E. coli ArsA and human ASNA1 both have ATPase activity in vitro (Karkaria et al., 1990; Kurdi-Haidar et al., 1996) . Purified C. elegans GST::ASNA-1 hydrolyzed ATP in vitro with a Km of 0.15 mM ( Figure 5C ). The specific ATPase activity for GST::ASNA-1 was 33.6 ± 0.9 (n = 8) nmol/min/mg protein. A transgene bearing an asna-1 construct with a mutation in the ATP binding site (Karkaria et al., 1990) that was expressed at levels similar to that of the rescuing transgenes ( Figure 5A ) failed to rescue the body size defect of asna-1(sv42) ( Figure 5B ) and failed to promote daf-8(e1393) exit from dauer (data not shown). Thus, ASNA-1 has ATPase activity in vitro, and this activity appears to be required for function in vivo.
Mammalian ASNA1 Is Expressed in Pancreatic b Cells and Promotes Insulin Release
To investigate whether ASNA1 was involved in insulin signaling in mammals, we first examined whether ASNA1 was expressed in cells that produce insulin in humans. Staining with anti-human ASNA1 antibodies (Kurdi-Haidar et al., 1998) revealed that in the pancreatic islets of Langerhans, ASNA1 was highly expressed in b cells ( Figure 3B ), but was not detectable in other pancreatic endocrine or exocrine cell types (data not shown). The dauer exit results suggested a role for asna-1 either in the production of insulin or its release. To distinguish between these possibilities, we tested the effect of increasing the dose of human ASNA1 in a mouse insulinoma cell line, NIT-1 (Hamaguchi et al., 1991) . For these experiments, NIT-1 cells were transfected with a plasmid encoding human ASNA1, pMS22. Individual clones were isolated and examined for their expression of ASNA1 protein. The two clones that produced the highest levels, S10 and S11, were chosen for further analysis. From a separate transfection, control clones were established that contained just the empty plasmid vector, pTarget (Promega, Madison, USA). Both S10 and S11, which produce approximately twice the normal levels of ASNA1, secreted significantly higher levels of insulin into the media in multiple independent experiments compared with empty vector-bearing cells (Figure 6 ). The increase in insulin levels in the media was not caused by 
Alleles used: daf-2(e1370), daf-7(e1372), daf-8(e1393), daf-1(m40), and daf-28(tm2308).
Transgenes: svIs54 (line 1) and svIs56 (line 2) were used for asna-1 overexpression. svEx352 was used for ins-4 overexpression, svEx434 for daf-28 overexpression, and svEx412 for P osm-6 :asna-1 overexpression. For all strains, embryos were collected from parents over a 6 hr period at 20 C, and the parents were then removed. Presence of nondauer animals (L4s and young adults) was scored after 96 hr as evidence of dauer exit. For transgenic daf-2 strains, the plates were screened again after 1 week to look for any nondauers. For all experiments, plates with a Daf-c mutant were incubated alongside the experimental plates to ensure that the temperature was nonpermissive for dauer exit in the absence of transgenes.
an increase in insulin production since the total cell content of proinsulin and insulin was not significantly different from that in NIT-1-derived clones derived from transformations with empty vector (Figure 6 ).
To examine whether reducing ASNA1 activity reduced the amount of insulin secreted into the media, we generated clones with constitutively reduced ASNA1 expression. For these experiments, a plasmid generating antisense ASNA1 transcripts, pMS23, was transfected into NIT-1 cells and individual clones were selected. Two independent clones were generated, AS13 and AS14, in which the amount of ASNA1 protein was approximately half that in the parent NIT-1 cells or in clones derived from transformations with empty vector. Clones with still lower ASNA1 expression were not possible to maintain in culture since they grew too slowly. The two clones with decreased ASNA1 levels both had reduced insulin secretion into the media (Figure 6 ).
Antisense against a control gene expressed in b cells did not affect ASNA1 protein levels ( Figure S2 ). We conclude that ASNA1 is involved in secretion rather than production of insulin. Clones with increased amounts of ASNA1 could still be stimulated to secrete more insulin by glucose. In four independent tests, glucose caused on average a 95% increase in the insulin secreted by the S10 ASNA1-overexpressing clone. The comparable figure for a clone generated with empty vector was 96%. Clones with reduced ASNA1 could also be stimulated to secrete insulin, although, in this case, the increase was less: glucose caused on average a 26% increase in insulin secreted by the ASNA1-underexpressing clone AS14.
C. elegans Worms with Reduced asna-1 Function Have Less Secreted DAF-28 Ins in the Pseudocoelom
To test whether reduction of asna-1 activity in C. elegans could affect secretion of insulin, we generated worms expressing a full-length DAF-28::GFP protein (from pVB298GK) and observed whether reducing asna-1 function altered its distribution. In wild-type worms, in addition to being in the amphid neurons and the gut, the protein is also found in coelomocytes (Figure 6 ), scavenger cells that constitutively endocytose material secreted into the psuedocoelom (Fares and Greenwald, 2001 ). In the coelomocytes, the full-length DAF-28::GFP protein was present in vacuoles that have been shown to take up the endocytosis marker FM4-64 (Fares and Greenwald, 2001) . daf-28::gfp transcriptional reporters are not expressed in coelomocytes (Li et al., 2003) (G.K., S.T., and P.N., unpublished data). The presence of DAF-28::GFP in coelomocytes, therefore, is the result of uptake of the protein from the psuedocoelomic fluid rather than that of transcription of daf-28 in these cells. The expression of a transcriptional DAF-28::GFP protein (from pVB252GK) in neurons or the intestine was similar to that in wild-type in asna-1(RNAi) animals, indicating that asna-1 is not required for the transcription of daf-28 or for the stability of the fusion protein. However, while wild-type animals expressing the full-length fusion protein always have GFPlabeled coelomocytes (n > 150), 20%-45% of the animals from three independent lines exposed to asna-1(RNAi) had no GFP-labeled coelomocytes (n = 73). Loss of asna-1 activity did not affect uptake of a fluid phase endocytosis marker, YP120::GFP, into coelomocytes, implying that asna-1 is not required for endocytosis in coelomocytes. Together, these observations suggest that less -1(sv42) ; svEx411 hermaphrodite. svEx411 is a transgene array containing pVB287GK (shown above) that encodes the mutant asna-1::gfp transgene. svEx411 fails to rescue the body size defect. (BC and BD) svEx411 hermaphrodite viewed with DIC (BC) or fluorescence (BD) optics at 6303 magnification. The asna-1 phenotype is not rescued even though the mutant fusion protein is expressed. (C) ATPase activity of a purified GST::ASNA-1 fusion protein plotted against ATP concentration. Fifty micrograms of protein were used for each measurement. Measurements were made in the concentration range of 0.05-1.6 mM ATP. Km = 0.15 ± 0.04. DAF-28::GFP protein is secreted into the psuedocoelom when asna-1 function is reduced.
DISCUSSION
Reduction in IIS activity in C. elegans causes entry into the dauer stage even under conditions conducive to reproductive growth. However, severe perturbations in the function of DAF-2, the insulin/IGF1 receptor homolog that regulates entry into dauer, cause arrest at the earlier developmental stage L1 (Gems et al., 1998) . We reasoned that some genes encoding proteins involved in IIS might not have been identified in genetic screens performed previously for those affecting the dauer decision because mutations in them would cause arrest earlier in development. Here we present the results of experiments on asna-1. Animals lacking asna-1 activity arrest reversibly at the L1 stage without obvious defects in pattern formation and have reduced IIS. asna-1::gfp reporter genes are expressed in a subset of neurons and in the intestine, tissues that produce insulin-like proteins including DAF-28. Secretion of DAF-28 into the body cavity is reduced in worms with decreased asna-1 activity. We show that overexpression of either daf-28 Ins or ins-4 Ins promotes exit from dauer and that increasing asna-1 function mimics the effects of daf-28 and ins-4 in a daf-2 ins/ IGFR receptor-dependent manner. The human homolog of asna-1 is expressed at high levels in pancreatic b cells, but not in a or d cells. Furthermore, increasing or reducing ASNA1 function in mouse insulinoma cells causes an increase or decrease, respectively, in insulin secretion.
In C. elegans L1 larvae hatched in the absence of food, cells are blocked in the G1 phase of the cell cycle and fail to divide. If the block on cell division is removed, for example by a reduction in the activity of the cell cycle regulator cki-1, some cell division occurs (Hong et al., 1998) . Constitutive activation of IIS causes ectopic cell division within the germline (Fukuyama et al., 2006) . These observations imply that cells in starved L1 larvae are not inherently unable to divide because of a lack of an essential metabolite required for cell growth or cell division. The fact that mutations in daf-2 ins/IGFR can cause arrest at the L1 stage strongly suggests that growth arrest is modulated systemically in part by at least one or more insulin-like proteins.
Mutations that cell autonomously block all postembryonic cell divisions in C. elegans would likely cause arrest Figure 6 . ASNA1 Promotes Insulin Secretion (A and B) Relative amounts of insulin secreted into the medium by cell clones derived from the mouse insulinoma cell line NIT-1. Medium was glucose-free KRB supplemented with 0.1% BSA. Data given are the mean ± SEM and were collected as duplicates in four independent experiments. Statistics were calculated using the Mann-Whitney U-test. *p < 0.05 versus NIT-1 empty vector cells. emv., clone derived by transformation with empty vector. (A) S11 and S10 are two clones that express elevated levels of human ASNA1. (B) AS13 and AS14 are two clones that express decreased levels of human ASNA1. Medium and statistics for (B) were as in (A). (C) (Top) total insulin and proinsulin content in cell clones expressing different levels of ASNA1. Clones are those described in (A) and (B). Medium and statistics were as in (A). Data given are the mean ± SEM and were collected as duplicates in three independent experi- at the L1 stage. It is unlikely, however, that the L1 arrest seen in worms lacking asna-1 activity reflects a cell autonomous requirement for asna-1 in cell division. First, no defects in cell division are seen in embryos lacking asna-1 activity or in larvae lacking zygotic gene activity. Second, expression of human ASNA1 under the control of tissuespecific promoters is sufficient to rescue the L1 arrest defect caused by asna-1(RNAi) (data not shown). Third, genetic mosaics demonstrate a cell nonautonomous requirement for asna-1 for growth. This cell nonautonomous requirement for asna-1 suggests instead that asna-1 is required for the action of one or more hormonal signals that promote growth. Our observations that IIS is reduced in asna-1 mutants and that overexpressing asna-1 mimics the effects of overexpressing insulin-like proteins strongly suggest that one way in which asna-1 promotes growth is by modulating the levels of one or more insulin-like proteins. High levels of ins-1, like asna-1(RNAi), cause L1 arrest (Pierce et al., 2001) . However, all ins-1(tm1888); asna-1(RNAi) animals also arrest as L1s (n = 158), implying that asna-1 cannot act solely by repressing the expression or activity of ins-1.
We have shown that the ability of asna-1 to stimulate exit from dauer is dependent upon daf-2 ins/IGFR. Thus, formally, asna-1 functions upstream of daf-2. Two observations suggest, however, that although asna-1 is required for activation of the pathway involving daf-2 in C. elegans, this is likely not ASNA-1's only function. First, while the daf-2 phenotype is fully suppressed by null mutations in daf- 16 FOXO, does not suppress the L1 arrest defect caused by loss of asna-1 activity (G.K., S.T., and P.N., unpublished data). Second, temperature-sensitive mutations that reduce IIS cause an increase in life span. asna-1 mutant adults rescued for the L1 arrest by maternal gene activity do not have increased life span. These differences suggest that asna-1's function is not mediated entirely by daf-16. It is possible that one or more of the INS proteins function not through DAF-2 but by a different receptor or receptors that do not act through DAF-16.
A yeast homolog of ASNA-1, Arr4/Get3, has been implicated in membrane trafficking within the secretory pathway (Schuldiner et al., 2005) . However, it is unlikely that ASNA-1 has a general role in secretion or in other membrane trafficking functions. RNAi with genes encoding proteins thought to have wide roles in secretion does not lead to reversible L1 arrest, but instead often causes a more severe phenotype (Table S3 ). Yeast cells lacking Get3 function also do not have nonspecific defects in secretion (Auld et al., 2006; Schuldiner et al., 2005) .
Our results with mammalian cells are consistent with the possibility that ASNA1 promotes one of the steps leading to the release of insulin from b cells. For example, ASNA1 could affect the activity of ion channels that regulate the docking of insulin-bearing dense core vesicles with the cell membrane in response to an increase in ATP levels. The fact that ASNA1 is itself an ATPase argues against a model in which ASNA1 functions by increasing ATP levels through promoting glycolysis or oxidative phosphorylation. The mechanism governing the secretion of insulin appears to be conserved in C. elegans (Ailion et al., 1999) . The fact that high asna-1 gene doses mimic the effects of increasing IIS in promoting exit from dauer implies that under these conditions asna-1 function in C. elegans is also rate limiting.
Concluding Remarks
This paper describes the identification of a positive regulator of insulin signaling that has been conserved in evolution. Genetic screens for mutations that cause reversible L1 arrest in C. elegans should allow the identification of proteins with which ASNA-1 acts as well as other factors involved in nutrient-dependent growth control in the worm. Given the degree of conservation of the mechanisms governing insulin release and those by which insulin and insulin-like proteins function, it seems probable that other genes involved in regulating L1 arrest will, like ASNA1, prove to have similar roles in mammals. Both ASNA1 and the proteins with which it acts are potential targets for drugs for the treatment of human diseases associated with defects in insulin metabolism.
EXPERIMENTAL PROCEDURES

C. elegans Techniques
Handling of C. elegans strains was as described (Brenner, 1974) . Experiments were carried out at 20 C unless otherwise stated. N2 is the wild-type parent for all strains used in this study. Injection RNAi and feeding RNAi were done as described (Fire et al., 1998) . sv42 was isolated from a frozen deletion library (Kao et al., 2004) . The external primers were ACGTCCTTTTGGCACGCATC and ACGAGTCGGCT CTACGTCAC. The internal primers were ACAGCTGCGGTGTGTG TTTC and CGCTCCAAATGGGAACGACG. The sv42 and the ok938 mutants were backcrossed to N2 seven times before use.
Plasmids
Plasmids used in this experiment are as follows:
pVB190GK: asna-1 cDNA cloned into feeding RNAi plasmid L4440. pBV202GK: P asna-1 ::hASNA1. pVB214GK: P asna-1 ::asna-1::GFP. GFP fused to the 8 th codon of asna-1. pVB222GK: P asna-1 ::asna-1::GFP. GFP fused to the last codon of asna-1. pVB252GK: P daf-28 ::daf-28::GFP. GFP fused to the 7 th codon of daf-28. pVB275GK: P elt-2 ::asna-1. Injected at 100 ng/ml. pVB281GK: ins-4 genomic fragment (Li et al., 2003) . pVB288GK: daf-28 genomic fragment driven by its own promoter. pVB287GK: Same as pVB222GK except for a 12 bp deletion in the Walker A motif that preserves the reading frame. pVB298GK:: P daf-28 ::daf-28::GFP. GFP fused to the last codon of daf-28. pVB308GK:: P osm-6 ::asna-1::GFP. GFP fused to the last codon of the asna-1 cDNA. Injected at 50 ng/ml.
Plasmid construction details are provided in the Supplemental Data.
ATPase Assay of GST::ASNA-1 Fusion Protein GST::ASNA-1 protein was purified from E. coli BL21 cells containing the full-length asna-1 cDNA cloned into pGEX-5X-2 by following the manufacturer's instructions (Amersham). ATPase activity was determined at room temperature using a standard assay in which ATP hydrolysis is coupled to the oxidation of NADH (Vogel and Steinhart, 1976) . The decrease in NADH concentration was monitored spectrophotometrically at 340 nm. The reaction buffer was 50 mM Hepes (pH 7.5), 30 mM KCl, 5 mM ATP, 4 mM phosphoenol pyruvate, 6 U lactate dehydrogenase, and 0.2 mM NADH, and the volume was 1 ml. The reaction was initiated by adding 5 mM MgCl and monitored for 15-20 min. The linear steady state rates between 5 and 10 min were used to calculate the specific activity at 340 nm.
Antibodies and Western Blots
Rabbit anti-worm ASNA-1 polyclonal antibodies were generated by immunizing animals with recombinant worm GST-ASNA-1 fusion protein (Agrisera, Sweden). The antibodies, used at 1:2000 dilution, detect a single 42 kDa protein band on western blots of worm lysates.
Pancreatic Tissues
Formalin-fixed and paraffin-embedded samples of normal human pancreas were obtained from patients who had undergone surgery at the Department of Surgery, Umeå University Hospital. The study was approved by the ethical committee at Umeå University.
Human Pancreas Tissue Staining ASNA1 was detected in formalin-fixed paraffin-embedded human pancreas tissue sections with the mouse antibody 5G8 (Kurdi-Haidar et al., 1998) . The sections were deparaffinized in xylene, rehydrated in ethanol, and treated with 5% Pronase in Tris-buffered saline (pH 7.2) for 18 min. Endogenous peroxidase activity was quenched with absolute methanol/3% H 2 O 2 for 20 min. Nonspecific binding was blocked with 10% horse serum in PBS for 30 min. The sections were incubated overnight in a moist chamber at 4 C with 5G8 diluted 1:50 in blocking solution. Insulin was detected by an anti-insulin antibody diluted 1:50,000 (Sigma). The Vector Elite ABC kit and biotinylated secondary antibodies (Vector Labs) were used to detect the primary antibodies with AEC chromogen. Slides were counterstained in hematoxylin. For immunoflorescence double-staining, a fluorescein anti-mouse IgM secondary antibody (Vector Labs) was used to detect 5G8 and a Texas red anti-mouse IgG secondary antibody (Vector Labs) was used to detect the anti-insulin primary antibody.
NIT-1 Cell Culture and Generation of Clones NIT-1 cells, a clonal NOD/Lt mouse insulinoma line (Hamaguchi et al., 1991) , were maintained in culture in F-12K media (Gibco Labs) supplemented with 10% fetal calf serum (FCS). NIT-1 clones expressing increased or decreased levels of ASNA1 were generated by introducing plasmids containing a human ASNA1 cDNA in the sense or antisense orientation under the control of a constitutively active Cytomegalovirus (CMV) promoter. Transfections were performed with the aid of lipofectamin (Life Technologies). Transformants were selected in complete medium containing 1 mg/ml G418 (Gibco Labs). After 3-4 weeks, single and independent cell clones were randomly isolated, and each individual clone was plated separately. After clonal expansion, cells were maintained in complete medium containing 0.3 mg/ml G418.
Insulin Secretion Experiments
NIT-1 wild-type, empty vector, sense ASNA1, and antisense ASNA1 plasmid bearing cells were grown in T25 cellular flasks, transferred to a 6-well plate, and cultured overnight to 60%-70% confluence. The cells were washed twice with glucose-free KRB (Krebs Ringer Bicarbonate) and then exposed to KRB with 0.1% BSA for 2 hr at 37 C.
The medium was then collected and centrifuged at 900 rpm for 5 min., and the supernatant was saved for insulin measurements. Proinsulin/ insulin concentration was measured with a rat RIA kit (RI-13K, Linco Research Inc). After removal of the medium, the cells were washed and lysed. The amount of protein in the cell lysates was measured.
For experiments with glucose, KRB-BSA media containing 3 mg/ml (16.7 mM) glucose was used in place of glucose-free KRB.
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.cell.com/cgi/content/full/128/3/577/DC1/.
